Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-09-000025
Filing Date
2009-05-11
Accepted
2009-05-11 14:53:14
Documents
1
Period of Report
2009-05-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4396
  Complete submission text file 0000875320-09-000025.txt   6179
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ECOSCIENCE CORP 10 ALVIN COURT EAST BRUNSWICK NJ 08816
Business Address
BOGER KENNETH S (Reporting) CIK: 0001046336 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 09814289
SIC: 2870 Agricultural Chemicals